FDA Artificial Intelligence Guidance: Draft Recommendations for AI-Enabled Devices
The U.S. Food and Drug Administration (FDA) recently released its draft guidance titled "Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submissions Recommendations." This draft comes at a crucial time as
Feb 04, 2025